OPN-FLU-NP-3103: A 16-Week prospective, randomized, double-blind, placebo controlled, parallel group, multicenter study evaluating the efficacy and safety of fluticasone propionate 186 μg twice a day using a exhalation delivery device in adolescents with chronic rhinosinusitis with bilateral nasal polyps.
Current Project
